echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Evrysdi treats spinal muscular atrophy (SMA), CHMP holds positive opinions

    Evrysdi treats spinal muscular atrophy (SMA), CHMP holds positive opinions

    • Last Update: 2021-03-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Roche today announced that the European Medicines Management Agency (EMA) Committee for Medicinal human use (CHMP) has recommended approval Evrysdi ™ (risdiplam) for the treatment of 5q spinal muscular atrophy (SMA) 2 months and older patients who suffer Type 1, Type 2, or Type 3 or one to four SMN2 copies of SMA.


    management

    SMA is the main genetic cause of infant death, and 5q SMA is the most common form of the disease.


    CHMP recommendations are based on data from FIREFISH clinical studies.


    In FIREFISH, according to the Bayley scale's total exercise scale assessment, 29% (12/41) of infants treated with Evrysdi for 12 months were able to sit for at least five seconds without support.


    Original source:

    Original source:

    https://target="_blank" rel="noopener">https:// style="vertical-align: inherit;"> https:// leave a message here

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.